Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
China Journal of Chinese Materia Medica ; (24): 4480-4487, 2021.
Artículo en Chino | WPRIM | ID: wpr-888149

RESUMEN

This study investigated the mechanism of improving impaired glucose tolerance(IGT) of rats by Huanglian Wendan Decoction from the perspective of the skeletal muscle Nod-like receptor protein 3(NLRP3)/cysteinyl aspartate specific proteinase-1(caspase-1)/interleukin-1β(IL-1β), interleukin-18(IL-18) pathway. Healthy male SD rats were fed with the diet containing 45% fat for 20 weeks, accompanied by a high-temperature and high-humidity environment and an inactive lifestyle, for the establishment of the IGT rat model. The rats were divided into the blank control group, model control group, metformin hydrochloride group(positive drug group, 0.05 g·kg~(-1)·d~(-1)) and Huanglian Wendan Decoction group(7.8 g·kg~(-1)·d~(-1)). After continuous intragastric administration for 4 weeks, the obesity and glycemic indexes of all the rats were measured. The fasting serum insulin(FINS) level was determined by ELISA, with the insulin sensitivity index(ISI) and insulin resistance index(IRI) calculated. The mRNA and protein expression le-vels of nuclear factor kappaB(NF-κB), NLRP3, caspase-1, IL-1β and IL-18 in skeletal muscle tissue were detected by real-time polymerase chain reaction(PCR), Western blot and immunofluorescence. Compared with the blank control group, the model control group witnessed significantly increased mRNA and protein expression of NF-κB, NLRP3, caspase-1, IL-1β and IL-18. As revealed by the comparison with the model control group, Huanglian Wendan Decoction could effectively regulate the obesity status, reduce body weight, correct the abnormal levels of 2-hour plasma glucose(2 hPG), insulin resistance index(IRI), insulin sensitivity index(ISI), and lower the mRNA and protein expression of NF-κB, NLRP3, caspase-1, IL-1β and IL-18 in the skeletal muscle tissue of IGT rats. Combined with previous studies, the above results showed that the occurrence and development of IGT was closely related to inflammatory response and the classic pyroptosis pathway in skeletal muscle, such as NLRP3/caspase-1/IL-1β, IL-18. It is inferred that the mechanism of Huanglian Wendan Decoction was to alleviate insulin resistance(IR) and then reverse the course of IGT lies in the regulation of the abnormal insulin receptor signaling pathway based on the NLRP3 inflammasome pathway.


Asunto(s)
Animales , Masculino , Ratas , Caspasa 1/genética , Medicamentos Herbarios Chinos , Intolerancia a la Glucosa , Interleucina-18/genética , Interleucina-1beta , Músculo Esquelético , FN-kappa B/genética , Proteína con Dominio Pirina 3 de la Familia NLR/genética , Ratas Sprague-Dawley
2.
Braz. j. infect. dis ; 23(6): 388-394, Nov.-Dec. 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1089306

RESUMEN

ABSTRACT Host immunogenetic setting is involved in the regulation of human papillomavirus (HPV) infection and development of condyloma acuminatum (CA). We investigated the correlation of two common single nucleotide polymorphisms (SNPs) (−607C/A and −137G/C) of IL-18 with the susceptibility of CA in a large Chinese cohort. Out of 408 CA patients analyzed, 300 had HPV infection transmitted through sexual contact (SC) and 108 through non-sexual contact (NSC). In addition, 360 healthy volunteers were enrolled as controls. SNPs at positions −607C/A and −137G/C in IL-18 promoter were analyzed. Comparing CA patients to healthy controls, no dominant relevance was found between the IL-18 promoter −607 C/A or −137G/C polymorphisms and the CA disease either identified genotypically (p > 0.05) or by allelically (p > 0.05). However, the IL-18 promoter −137G/C polymorphism genotype and allele frequencies in the NSC CA group, but not between in the SC group, were significantly higher than in the controls. There was no dominant relevance between IL-18-607C/A polymorphism genotype and allele frequencies among SC, NSC CA patients, and controls. Our study demonstrates that polymorphism −137G/C in IL-18 promoter is significantly correlated with risk of CA in NSC patients.


Asunto(s)
Humanos , Masculino , Femenino , Condiloma Acuminado/genética , Interleucina-18/genética , Polimorfismo de Nucleótido Simple/genética , Infecciones por Papillomavirus/complicaciones , Polimorfismo Genético , Condiloma Acuminado/virología , China , Estudios de Cohortes , Regiones Promotoras Genéticas , Predisposición Genética a la Enfermedad , Infecciones por Papillomavirus/transmisión , Pueblo Asiatico/genética , Alelos , Genotipo
3.
Journal of Korean Medical Science ; : 382-387, 2012.
Artículo en Inglés | WPRIM | ID: wpr-25824

RESUMEN

Lower respiratory symptoms in bakery workers may be induced by wheat flour and endotoxins. We hypothesized that endotoxins from wheat flour may stimulate innate immunity and that interleukin-18 (IL-18) gene polymorphisms may affect their regulatory role in innate immune responses to endotoxins. To investigate the genetic contribution of IL-18 to sensitization to wheat flour, we performed a genetic association study of IL-18 in Korean bakery workers. A total of 373 bakery workers undertook a questionnaire regarding work-related symptoms. Skin prick tests with common and occupational allergens were performed and specific antibodies to wheat flour were measured by ELISA. Three polymorphisms of the IL-18 gene (-607A/C, -137G/C, 8674C/G) were genotyped, and the functional effects of the polymorphisms were analyzed using the luciferase reporter assay. Genotypes of -137G/C (GC or CC) and haplotype ht3 [ACC] showed a significant association with the rate of sensitization to wheat flour. Luciferase activity assay indicated ht3 [AC] as a low transcript haplotype. In conclusion, the regulatory role of IL-18 in lipopolysaccharide-induced responses in bakery workers may be affected by this polymorphism, thus contributing to the development of sensitization to wheat flour and work-related respiratory symptoms.


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Alelos , Alérgenos/inmunología , Anticuerpos/análisis , Genes Reporteros , Genotipo , Haplotipos , Interleucina-18/genética , Enfermedades Profesionales/genética , Polimorfismo de Nucleótido Simple , Encuestas y Cuestionarios , Hipersensibilidad Respiratoria/genética , Pruebas Cutáneas , Triticum/inmunología
4.
Yonsei Medical Journal ; : 1008-1015, 2011.
Artículo en Inglés | WPRIM | ID: wpr-116324

RESUMEN

PURPOSE: Bacillus Calmette-Guerin (BCG) vaccine has widely been used to immunize against tuberculosis, but its protective efficacy is variable in adult pulmonary tuberculosis, while it is not efficiently protective against progressive infection of virulent Mycobacterium tuberculosis strains. In this study, the protective effects of plasmid DNA vaccine constructs encoding IL-12 or IL-18 with the BCG vaccine were evaluated against progressive infection of M. tuberculosis, using mouse aerosol challenge model. MATERIALS AND METHODS: Plasmid DNA vaccine constructs encoding IL-12 or IL-18 were constructed and mice were immunized with the BCG vaccine or with IL-12 DNA or IL-18 DNA vaccine constructs together with the BCG vaccine. RESULTS: The BCG vaccine induced high level of interferon gamma (IFN-gamma) but co-immunization of IL-12 or IL-18 DNA vaccine constructs with the BCG vaccine induced significantly higher level of IFN-gamma than a single BCG vaccine. The BCG vaccine was highly protective at early stage of M. tuberculosis infection, but its protective efficacy was reduced at later stage of infection. The co-immunization of IL-12 DNA vaccine constructs with the BCG vaccine was slightly more protective at early stage of infection and was significantly more protective at later stage infection than a single BCG vaccine. CONCLUSION: Co-immunization of IL-12 DNA vaccine with the BCG vaccine induced more protective immunity and was more effective for protection against progressive infection of M. tuberculosis.


Asunto(s)
Animales , Femenino , Ratones , Vacuna BCG/inmunología , Técnicas para Inmunoenzimas , Interferón gamma/sangre , Interleucina-12/genética , Interleucina-18/genética , Ratones Endogámicos C57BL , Plásmidos/genética , Tuberculosis/sangre , Vacunas de ADN/genética
5.
Journal of Gorgan University of Medical Sciences. 2011; 13 (1): 66-72
en Persa | IMEMR | ID: emr-130044

RESUMEN

Visceral leishmaniasis [VL] is a parasitic disease caused by a protozoan of Leishmania genus and in Iran by Leishmania infantum. The protective immune response against VL is cellular immunity through Th1 CD4+, which dominant chemokiens are IL12, IFN-alpha and IL18 and lead to Th1 response. Single nucleotide polymorphism [SNP] on IL-18 gene and its relation to IL18 levels in blood and IL18 function have been studied in many inflammatory diseases such as Behcect's disease and tuberculosis. According to the important role of IL-18 in immunity against visceral leishmaniasis, this study was conducted to demonstrate the prevalence of genotypes on-607A/C in promoter region of IL-18 gene. This descriptive and cross-sectional study was done on 91 pateints with confirmed VL, 105 healthy sero-negative controls and 78 seropositive controls during 1999-2009. Salting out method was used to extract DNA and ARMS-PCR was used to determine the genotype of-607A/C allele of individuals. Statistical analysis of genotypes was performed using Chi-Square test. According to the results,-607C/C was the dominant genotype among the groups [35.8%]. Distribution of genotypes among groups had not any significant difference. The lowest genotype among healthy sero-positive and patients were-607A/C and-607A/A, respectively. Statistical analysis of distribution of genotypes, did not reveal any significant difference among groups. The dominant genotypes of VL patients, healthy sero-negatives and healthy seropositives were-607C/C [38.5%],-607A/C [37.1%] and-607C/C [35.9%] respectively


Asunto(s)
Humanos , Leishmaniasis Visceral/genética , Interleucina-18/genética , Polimorfismo Genético , Prevalencia , Estudios Transversales , Reacción en Cadena de la Polimerasa
6.
Asian Pac J Allergy Immunol ; 2007 Dec; 25(4): 233-42
Artículo en Inglés | IMSEAR | ID: sea-36563

RESUMEN

Hepatitis B is a global serious disease caused by hepatitis B virus (HBV). There is no known cure for hepatitis B. The best way to deal with the disease is by preventing with hepatitis B vaccine. However, the current protein-based vaccines made up of recombinant hepatitis B surface antigen (HBsAg) are ineffective in chronic HBV carriers and a significant number of the vaccinees do not mount the protective immune response. Novel DNA-based immunization may overcome the deficits of the protein-based immunization and may provide more effective prophylactic and therapeutic outcomes. In this study, we constructed a recombinant plasmid carrying gene encoding the HBV surface antigen (HBs) linked to DNA segment encoding full-length murine interleukin-18, i.e. pcDNA-HBs-IL-18. Immunogenicity of the DNA construct was carried out in BALB/c mice in comparison with mock, i.e. pcDNA3.1+ and vaccines comprised of pRc/CMV-HBs and pRc/CMV-HBs plus pcDNA-IL-18. All vaccinated mice revealed significant serum anti-HBs IgG response after two intramuscular injections of the vaccines at 28 day interval as compared to the level of mock. Co-administration of pRc/CMV-HBs and pcDNA-IL-18 elicited arbitrarily higher levels of anti-HBs IgG than the levels in mice immunized with pRc/CMV-HBs alone and mice that received pcDNA-HBs-IL-18 although not statistically different. Further experiments are needed to investigate the subisotypes of the IgG antibody, the kinetics of cytokine and the cell-mediated immune response. For this communication, the prototype HBs-IL-18 DNA vaccine was successfully constructed and the gene encoding murine IL-18 was successfully cloned. The latter can be co-injected with the antigen coding DNA or used as a fusion partner to the DNA for priming the immune response. The recombinant HBs and full-length IL-18 proteins have potential for other research purposes. They may be used also as standard proteins in the protein quantification assay.


Asunto(s)
Animales , Anticuerpos Antivirales/inmunología , Hepatitis B/genética , Antígenos de Superficie de la Hepatitis B/genética , Vacunas contra Hepatitis B/genética , Virus de la Hepatitis B/genética , Humanos , Inmunidad Celular , Inmunoglobulina G/inmunología , Interleucina-18/genética , Ratones , Ratones Endogámicos BALB C , Proteínas Recombinantes de Fusión/genética , Vacunas de ADN/genética
7.
Experimental & Molecular Medicine ; : 574-582, 2006.
Artículo en Inglés | WPRIM | ID: wpr-69440

RESUMEN

Xenotransplantation, the transplantation of cells, tissues or organs between individuals of different species, would resolve the current shortage of organs, but rejection remains the major hurdle to successful xenotransplantation. In the present study, we analyzed mixed lymphocyte reactions (MLRs) and used 51Cr release assays in order to identify the proliferation and expansion of mouse CD8+ cytotoxic T lymphocyte cells against PK15, PK15/pIL-18 or PK15/mIL-18 cells. In addition, we identified T cell populations in mouse splenocytes and lymph node cells using two-color flow cytometry. It was found that the CD8+T cells of xenograft recipients proliferated extensively and that the survival rates of populations of PK15/mIL-18 or PK15/pIL-18 cells were higher than untransfected controls. Moreover, CD3+T cells were increased in mice injected with PK15 cells or PK15/pIL-18 cells but PK15/pIL-18 cell numbers were lower in lymph nodes than untransfected controls. CD8+T cells numbers were reduced in the lymph nodes of PK15/pIL-18 injected mice. These results suggest that porcine IL-18 regulates anti-pig cellular rejection in C57BL/6 mice.


Asunto(s)
Ratones , Femenino , Animales , Trasplante Heterólogo , Trasplante , Transgenes/inmunología , Transfección , Distribución Tisular , Linfocitos T/metabolismo , Porcinos , ARN Mensajero/metabolismo , Fenotipo , Ratones Endogámicos C57BL , Prueba de Cultivo Mixto de Linfocitos , Activación de Linfocitos , Riñón/citología , Interleucina-18/genética , Terapia de Inmunosupresión/métodos , Rechazo de Injerto/inmunología , Vectores Genéticos/síntesis química , Células Epiteliales/efectos de los fármacos , Citocinas/metabolismo , Células Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA